True Bearing Diagnostics, Inc.

This invitation-only healthcare investment conference, held in San Francisco from January 9-12, is the premiere conference for healthcare investors and biotechnology/healthcare companies.

You can view the original clinical study that identifies some of the key TruNAV markers here: on the free full text at upper right.

True Bearing scientists publish key discovery and validation of the TruCAD RNA biomarkers for Coronary Artery Disease.

An article and interview outlining our future plans.